United Kingdom · Question · Written question
UIN 16655
Prostate Cancer: Screening
Original
Introduced
27 November 2024
Last action
2 December 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
2 December 2024
Summary
To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that guidance to primary care clinicians on screening for prostate cancer includes reference to the potential impact of the BRCA2 gene variation on risk levels.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
27 November 2024
Written question
To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that guidance to primary care clinicians on screening for prostate cancer includes reference to the potential impact of the BRCA2 gene variation on risk levels.
Source: Commons
2 December 2024
Answer
The Prostate Cancer Risk Management Programme provides guidance for general practitioners on how to counsel men who have no symptoms but wish to have a Prostate Specific Antigen (PSA) test for prostate cancer. It highlights the potential benefits and harm...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-11-27/16655
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1745256
- uk · wq-1745256 · source updated 2 December 2024